Skip to content

Evaluation of the clinical efficacy of concurrent combined surgery and deferred treatment in the young adult with mdifacial fractures and craniocerebral injury

Evaluation of the clinical efficacy of concurrent combined surgery and deferred treatment in the young adult with mdifacial fractures and craniocerebral injury

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030531
Enrollment
Unknown
Registered
2020-03-06
Start date
2020-03-09
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillofacial Trauma

Interventions

experimental group:concurrent combined surgery
Control group:deferred treatment in different departments

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients are 18-59 years of age; 2. Definitive diagnosis of midfacial fracture with facial asymmetry and malocclusion; 3. Definitive diagnosis of neurosurgery: (1) Acute epidural hematoma with obvious mass effect; (2) Skull base fracture with cerebrospinal fluid leakage requiring surgical repair; (3) Skull fracture with significant displacement affecting function and appearance; (4) Severe craniocerebral injury without cerebral hernia Or the hernia time is less than 2 hours; 4. Patients with a Glasgow Coma Scale of 8 or more before neurosurgery. 5. Patients who can cooperate with our treatment.

Exclusion criteria

Exclusion criteria: 1. Previous cranio-maxillofacial surgery history; 2. Patients with craniocerebral trauma that seriously threatens the patient's life and cannot endure long-term surgery; 3. Patients with craniocerebral trauma with poor prognosis, such as brain stem injury, and high probability of postoperative plant survival 4. Patients with poor general conditions and severe systemic diseases, including those with acute infections, mental illnesses and hypertension, heart disease, and diabetes; 5. Patients with systemic and local diseases that affect the prognosis of treatment such as osteoporosis, osteomyelitis, etc; 6. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Accuracy of fracture reduction;Glasgow Coma Scale;

Secondary

MeasureTime frame
Facial symmetry;Mouth opening;Occlusion;Efficiency of surgery;Inpatient days;

Countries

China

Contacts

Public ContactShilei Zhang

Shanghai Ninth People's Hospital, Shanghai Jiaotong University, School of Medicine

leinnymd@hotmail.com+86 13701689301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026